Mumbai: Pharma Major, Unichem Laboratories Ltd’s API manufacturing facility at Pithampur, Madhya Pradesh was inspected by USFDA from July 23-27 2018.
Four observations were made which do not impact continuity of the Company’s business and its manufacturing activity, the company said in a filing with BSE.
The Company proposes to respond to these observations within 15 business days.
The Pithampur facility manufactures API for use in the production of formulations that are exported to the USA.
0 comment(s) on Unichem Labs gets USFDA observations for its Pithampur API facility
